Valued at a market cap of $217 billion, Abbott Laboratories (ABT) is a healthcare company that develops, manufactures, and sells a broad range of medical devices, diagnostics, nutrition products, and branded generic pharmaceuticals. The North Chicago, Illinois-based company is expected to announce its fiscal Q4 earnings for 2025 in the near future. Ahead of this event, analysts expect this healthcare company to report a profit of$1.50 per share, up 11.9% from $1.34 per share in the year-ago quarter. The ...